Scoping Review consultations

Conveners
Love Alliance; HIV Policy Lab
Role
Led the organisation and facilitation of the consultations on behalf of the HIV Policy Lab — presenting the scoping review and its emerging findings and guiding partner discussions throughout
Date
February – July 2022
Location
Virtual

The Types, Costs, Benefits and Resourcing of Community-led and Other Responses for SRHR scoping review was built on an extended programme of consultation with the Love Alliance partners, bilateral partners and civil society. Juliette led the HIV Policy Lab’s organisation and facilitation of these consultations — presenting the review and its emerging findings, and guiding the discussions that shaped both its methodology and the actionable recommendations set out in the companion policy report.

Bilateral consultations — February to May 2022

Bilateral consultations informing the development of the scoping review were convened with amfAR, UNAIDS, the Gates Foundation, MSF, and Acceso Global / AMPG Health.

Love Alliance consultations on policy priorities and research needs — 3–4 May 2022

Two consecutive consultations convened by the Love Alliance Advocacy Working Group and the HIV Policy Lab. The first (3 May) focused on defining up to five policy advocacy briefs to inform Love Alliance advocacy and grant-making in 2022–2023, drawing on the emerging findings of the scoping review. The second (4 May) identified research priorities to inform Love Alliance-initiated work to follow.

Participant organisations included the Love Alliance, AidsFonds, GNP+, Sisonke South Africa, UHAI EASHRI, AMPG Health, AFEMENA, INPUD, Sidaction Paris, ISDAO, GALZ, Soa Aids Netherlands, Mainline Netherlands, Robert Carr Fund, COC Netherlands, NSWP, SANPUD and TB HIV Care.

Scoping review presented to the Love Alliance Advocacy Working Group — 23 June 2022

Presentation of the scoping review to the Love Alliance Advocacy Working Group, with participants from AidsFonds, UHAI EASHRI, Mouvement Burundi, ISDAO, Y+ Global, Sisonke, GNP+, MPact Global, INPUD, SANPUD, LAMBDA, NSWP, GALZ and the Global Fund. A follow-up discussion on 8 July 2022 continued the conversation with INPUD, NSWP, AidsFonds and GNP+.

The consultations fed directly into two publications: